136 related articles for article (PubMed ID: 2466598)
1. [Amine metabolites in cerebrospinal fluids and thyrotropin releasing hormone in spinocerebellar degeneration].
Arai M
Rinsho Shinkeigaku; 1988 Jun; 28(6):595-604. PubMed ID: 2466598
[No Abstract] [Full Text] [Related]
2. [CSF somatostatin and amine metabolites in spinocerebellar degenerations].
Shimoda K; Hikasa C; Nishikawa S; Takahashi K
Rinsho Shinkeigaku; 1987 Aug; 27(8):996-1001. PubMed ID: 2446812
[No Abstract] [Full Text] [Related]
3. [Efficacy of TRH-T for spinocerebellar degeneration--the relation between clinical features and effect of TRH therapy].
Waragai M; Ogawara K; Takaya Y; Hayashi M
Rinsho Shinkeigaku; 1997 Jul; 37(7):587-94. PubMed ID: 9396355
[TBL] [Abstract][Full Text] [Related]
4. Correlations between height of subject and concentrations of monoamine metabolites in cerebrospinal fluid from psychotic men and women.
Wode-Helgodt B; Sedvall G
Commun Psychopharmacol; 1978; 2(2):177-83. PubMed ID: 668302
[No Abstract] [Full Text] [Related]
5. Amine metabolites in the cerebrospinal fluid as a measure of central neurotransmitter function: methodological aspects.
Bertilsson L; Asberg M
Adv Biochem Psychopharmacol; 1984; 39():27-34. PubMed ID: 6205559
[No Abstract] [Full Text] [Related]
6. Biogenic amine metabolites in cerebrospinal fluid of patients with affective disorders.
Vestergaard P; Sørensen T; Hoppe E; Rafaelsen OJ; Yates CM; Nicolaou N
Acta Psychiatr Scand; 1978 Jul; 58(1):88-96. PubMed ID: 696380
[No Abstract] [Full Text] [Related]
7. Effects of anticonvulsant treatment and low levels of folate and thiamine on amine metabolites in cerebrospinal fluid.
Botez MI; Young SN
Brain; 1991 Feb; 114 ( Pt 1A)():333-48. PubMed ID: 1705463
[TBL] [Abstract][Full Text] [Related]
8. Amine metabolites in cerebrospinal fluid from Huntigton's chorea patients treated with lithium.
Vestergaard P; Yates CM
Clin Chim Acta; 1978 Jul; 87(2):297-9. PubMed ID: 148982
[No Abstract] [Full Text] [Related]
9. CSF monoamine metabolites, depression, and suicide.
Asberg M; Bertilsson L; Mårtensson B
Adv Biochem Psychopharmacol; 1984; 39():87-97. PubMed ID: 6205566
[No Abstract] [Full Text] [Related]
10. Genetic studies of CSF monoamine metabolites.
Sedvall G; Iselius L; Nybäck H; Oreland L; Oxenstierna G; Ross SB; Wiesel FA
Adv Biochem Psychopharmacol; 1984; 39():79-85. PubMed ID: 6205565
[No Abstract] [Full Text] [Related]
11. [Concentrations of monoamines and monoamine metabolites in cerebrospinal fluid determined by high-performance liquid chromatography with electrochemical detection].
Yoshino K
No To Shinkei; 1982 Nov; 34(11):1099-106. PubMed ID: 6186264
[TBL] [Abstract][Full Text] [Related]
12. Reduction of biogenic amine levels in the Rett syndrome.
Zoghbi HY; Percy AK; Glaze DG; Butler IJ; Riccardi VM
N Engl J Med; 1985 Oct; 313(15):921-4. PubMed ID: 2412119
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous determination of the three major monoamine metabolites in CSF by HPLC with electrochemical detection.
Van Bockstaele M; Dillen L; Claeys M; De Potter WP
Arch Int Pharmacodyn Ther; 1982 Dec; 260(2):304-5. PubMed ID: 6187306
[No Abstract] [Full Text] [Related]
14. [Spinocerebellar degeneration and neuropeptides].
Matsuoka Y; Sakurai N
Nihon Naika Gakkai Zasshi; 1989 Dec; 78(12):1705-8. PubMed ID: 2516527
[No Abstract] [Full Text] [Related]
15. Aminergic metabolites in cerebrospinal fluid of humans previously exposed to MDMA: preliminary observations.
Ricaurte GA; Finnegan KT; Irwin I; Langston JW
Ann N Y Acad Sci; 1990; 600():699-708; discussion 708-10. PubMed ID: 1701292
[No Abstract] [Full Text] [Related]
16. Lithium: clinical effects and cerebrospinal fluid acid monoamine metabolites.
Bowers MB; Heninger GR
Commun Psychopharmacol; 1977; 1(2):135-45. PubMed ID: 603996
[No Abstract] [Full Text] [Related]
17. [Changes in the CSF levels of monoamine metabolites in 102 chronic schizophrenic patients following probenecid before and after neuroleptic medication].
Chen YF
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1984 Oct; 17(5):273-7. PubMed ID: 6085683
[No Abstract] [Full Text] [Related]
18. Cerebrospinal fluid measurements suggest precursor availability and sex are involved in the control of biogenic amine metabolism in a primate.
Young SN; Ervin FR
J Neurochem; 1984 Jun; 42(6):1570-3. PubMed ID: 6202838
[TBL] [Abstract][Full Text] [Related]
19. Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity?
Scheinin M
Med Biol; 1985; 63(1):1-17. PubMed ID: 2582215
[TBL] [Abstract][Full Text] [Related]
20. [Effects of thyrotropin-releasing hormone on neurologic recovery and biogenic amine metabolites of cerebrospinal fluid in spinal disorders].
Hirofuji E; Tanaka S
Nihon Seikeigeka Gakkai Zasshi; 1989 Nov; 63(11):1306-15. PubMed ID: 2515232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
